标普生物科技LOF(161127)

动态评分: 5.92分

投资组合

报告日期 名称 比例
2023-12-31 Ionis Pharmaceuticals Inc 1.12%
2023-12-31 Nuvalent Inc-A 1.12%
2023-12-31 PTC Therapeutics Inc 1.12%
2023-12-31 拜玛林制药 1.12%
2023-12-31 艾伯维 1.12%
2023-12-31 Beam Therapeutics Inc 1.11%
2023-12-31 吉利德科学 1.1%
2023-12-31 ImmunoGen Inc 1.09%
2023-12-31 CRISPR Therapeutics AG 1.04%
2023-12-31 Syndax Pharmaceuticals Inc 1.04%
2023-12-31 Crinetics Pharmaceuticals Inc 1.04%
2023-12-31 Apellis Pharmaceuticals Inc 1.03%
2023-12-31 Ardelyx Inc 1.02%
2023-12-31 Twist Bioscience Corp 1.01%
2023-12-31 奥洛兹美医疗 1%
2023-12-31 联合治疗 0.98%
2023-12-31 Ironwood Pharmaceuticals Inc-A 0.97%
2023-12-31 Viking Therapeutics Inc 0.93%
2023-12-31 诺瓦瓦克斯医药 0.93%
2023-12-31 德纳维制药 0.91%

投资模拟

公告&资料